Campbell Shannon — SEC Form 4 filings

SEC reporting owner CIK 2018966. 8 Form 4 filings on record with FilingPulse; latest filed 2026-06-29.

Transaction summary — filings shown

Covers all 8 filings on record, filed 2024-04-12 to 2026-06-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Black Diamond Therapeutics, Inc. (BDTX)Director77
Zentalis Pharmaceuticals, Inc. (ZNTL)Director11

Form 4 filings — Campbell Shannon

FiledFormIssuerReported transactionsSource
2026-06-294Black Diamond Therapeutics, Inc. (BDTX)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2026-05-274Zentalis Pharmaceuticals, Inc. (ZNTL)Grant/award (A): 114,200 @ $0EDGAR
2025-06-124Black Diamond Therapeutics, Inc. (BDTX)Grant/award (A): 30,550 (derivative) @ $0EDGAR
2024-12-164Black Diamond Therapeutics, Inc. (BDTX)Grant/award (A): 4,500 @ $2.50EDGAR
2024-09-204Black Diamond Therapeutics, Inc. (BDTX)Grant/award (A): 2,354 @ $4.78EDGAR
2024-06-214Black Diamond Therapeutics, Inc. (BDTX)Grant/award (A): 2,011 @ $4.98EDGAR
2024-06-064Black Diamond Therapeutics, Inc. (BDTX)Grant/award (A): 30,550 (derivative) @ $0EDGAR
2024-04-124Black Diamond Therapeutics, Inc. (BDTX)Grant/award (A): 61,100 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2018966 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →